The reputation of the breast cancer drug tamoxifen has taken another serious knock following the publication of two European trials that show it is not a cancer preventative. ...
This month, the instructive case study about terrible doctoring comes from my own back yard. ...
New evidence from two studies show that women who take tamoxifen to prevent or treat breast cancer are at greater risk of endometrial abnormalities, including cancer. ...
Recently, you probably saw the newspaper articles about "new fears" raised by tamoxifen, the drug used to prevent and treat breast cancer. The stories concerned a Dutch case control study publish ...
Women who take tamoxifen to prevent breast cancer are getting too much of the drug, according to new evidence. ...
...
Many of the side effects of tamoxifen may be worth risking if you have cancer. However the risk/benefit equation changes considerably if you are healthy and offered the drug as a just in case mea ...
Yet another clinical trial of tamoxifen can’t decide if the drug is worth taking.
Originally hailed as a major contribution to breast cancer prevention, tamoxifen has had a bumpy ride
The drug company giveth, and it taketh away, too. The thought came to mind after we looked at the success of the drug tamoxifen in fighting - and preventing - breast cancer. Unfortunately it's likely to give you endometrial cancer instead. But it...
Oncologists often have only one strategy when dealing with breast cancer: stop the flow of oestrogen to the tumour. Although only half of all breast cancers depend on oestrogen, it’s become a one-size-fits-all approach.
